These findings indicate that IPF MPC-derived IL-8 is capable of expanding the mesenchymal cell population and recruiting activated macrophages cells to actively evolving fibrotic lesions. The gene discussed is CXCL8; the disease is idiopathic pulmonary fibrosis.